New treatment option for Implantable Defibrillator User
Official title Self-Management Interventions After an ICD Shock
ClinicalTrials.gov ID: NCT06037785
What this study is testing
- What it's testing
- This study, "Biobehavioral Intervention to Reduce PTSD Symptoms After an ICD Shock," addresses a critical need in cardiology care by describing the feasibility and acceptability of a timely, highly promising, electronically-delivered intervention for patients who have recently received an ICD delivered shock. The study intervention and outcomes are designed to reduce anxiety, enhance return to activities of daily living (ADLs), and prevent the development of severe distress and post-traumatic stress disorder (PTSD), and ultimately promote quality of life.
- Time commitment: about 1 month
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- ICD implant for primary or secondary prevention of sudden cardiac arrest (SCA),
- receipt of at least 1 ICD shock, appropriate or inappropriate, one week prior to enrollment;
- able to read, speak and write English;
- access to online resources and telephone for study duration.
You likely can't join if
- current diagnosis of PTSD, schizophrenia or bipolar disorder;
- Short BLESSED score \>6 indicating cognitive dysfunction [73];
- age \<18 years;
- AUDIT-C score ≥4 for alcohol use;
- regular non-medical use of illicit drugs
The study team makes the final eligibility decision.
Where it's taking place
- Seattle, Washington, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The study runs about 1 month per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Seattle, Washington, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.